Anemia in Frailty

Clinics in Geriatric Medicine

Volumn 27, Issue 1, 2011, Pages 67-78

  Roy, Cindy N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Disability; Frailty; Hemoglobin; Inflammation; Older adult

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANEMIC AGENT; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN STIMULATING AGENT; HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SALICYLIC ACID DERIVATIVE; TOCILIZUMAB; UNCLASSIFIED DRUG;

ANEMIA; BLOOD TRANSFUSION; CHRONIC INFLAMMATION; CLINICAL TRIAL; COGNITIVE DEFECT; DIGESTIVE SYSTEM HEMORRHAGE; DISABILITY; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; FATIGUE; FRAIL ELDERLY; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SYNTHESIS; HUMAN; INCIDENCE; INFECTION; IRON DEFICIENCY; LIVER DYSFUNCTION; LONGEVITY; MORTALITY; PATHOGENESIS; PHYSICAL PERFORMANCE; PRACTICE GUIDELINE; PREVALENCE; QUALITY OF LIFE; REFERENCE VALUE; REVIEW; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ANEMIA; C-REACTIVE PROTEIN; FEMALE; FRAIL ELDERLY; HEMOGLOBINS; HUMANS; INTERLEUKIN-6; MALE; OXIDATIVE STRESS;

EID: 78549237164     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2010.08.005     Document Type: Review

References (83)

1. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968, 405:5-37.
2. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004, 104(8):2263-2268.
3. Izaks G.J., Westendorp R.G., Knook D.L. The definition of anemia in older persons. JAMA 1999, 281(18):1714-1717.
4. Zakai N.A., Katz R., Hirsch C., et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005, 165(19):2214-2220.
5. Denny S.D., Kuchibhatla M.N., Cohen H.J. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 2006, 119(4):327-334.
6. Penninx B.W., Pahor M., Woodman R.C., et al. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci 2006, 61(5):474-479.
7. Milman N., Pedersen A.N., Ovesen L., et al. Hemoglobin concentrations in 358 apparently healthy 80-year-old Danish men and women. Should the reference interval be adjusted for age?. Aging Clin Exp Res 2008, 20(1):8-14.
8. Chaves P.H., Ashar B., Guralnik J.M., et al. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated?. J Am Geriatr Soc 2002, 50(7):1257-1264.
9. Penninx B.W., Pahor M., Cesari M., et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004, 52(5):719-724.
10. Chaves P.H., Carlson M.C., Ferrucci L., et al. Association between mild anemia and executive function impairment in community-dwelling older women: the Women's Health and Aging Study II. J Am Geriatr Soc 2006, 54(9):1429-1435.
11. Chaves P.H., Xue Q.L., Guralnik J.M., et al. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?. J Am Geriatr Soc 2004, 52(11):1811-1816.
12. Dong X., Mendes de Leon C., Artz A., et al. A population-based study of hemoglobin, race, and mortality in elderly persons. J Gerontol A Biol Sci Med Sci 2008, 63(8):873-878.
13. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56(3):M146-M156.
14. Patel K.V., Longo D.L., Ershler W.B., et al. Haemoglobin concentration and the risk of death in older adults: differences by race/ethnicity in the NHANES III follow-up. Br J Haematol 2009, 145(4):514-523.
15. Artz A.S. Anemia and the frail elderly. Semin Hematol 2008, 45(4):261-266.
16. Thein M., Ershler W.B., Artz A.S., et al. Diminished quality of life and physical function in community-dwelling elderly with anemia. Medicine 2009, 88(2):107-114.
17. Cesari M., Penninx B.W., Lauretani F., et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004, 59(3):249-254.
18. Deal J.A., Carlson M.C., Xue Q.L., et al. Anemia and 9-year domain-specific cognitive decline in community-dwelling older women: the Women's Health and Aging Study II. J Am Geriatr Soc 2009, 57(9):1604-1611.
19. Joosten E., Pelemans W., Hiele M., et al. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology 1992, 38(1-2):111-117.
20. Ferrucci L., Guralnik J.M., Bandinelli S., et al. Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 2007, 136(6):849-855.
21. Walston J., McBurnie M.A., Newman A., et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002, 162(20):2333-2341.
22. Hanada T., Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002, 13(4-5):413-421.
23. Ghosh S., Hayden M.S. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008, 8(11):837-848.
24. Yeung F., Hoberg J.E., Ramsey C.S., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23(12):2369-2380.
25. Kawahara T.L., Michishita E., Adler A.S., et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136(1):62-74.
26. Lin L., Hron J.D., Peng S.L. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 2004, 21(2):203-213.
27. Sun W.H., Keller E.T., Stebler B.S., et al. Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun 1998, 244(3):691-695.
28. Keller E.T., Chang C., Ershler W.B. Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem 1996, 271(42):26267-26275.
29. Adler A.S., Kawahara T.L., Segal E., et al. Reversal of aging by NFkappaB blockade. Cell Cycle 2008, 7(5):556-559.
30. Yu B.P., Chung H.Y. Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev 2006, 127(5):436-443.
31. Cartwright G.E. The anemia of chronic disorders. Semin Hematol 1966, 3:351-375.
32. Leng S.X., Xue Q.L., Tian J., et al. Inflammation and frailty in older women. J Am Geriatr Soc 2007, 55(6):864-871.
33. Ershler W.B. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 1993, 41(2):176-181.
34. Eisenstaedt R., Penninx B.W., Woodman R.C. Anemia in the elderly: current understanding and emerging concepts. Blood Rev 2006, 20(4):213-226.
35. Ershler W.B. Biological interactions of aging and anemia: a focus on cytokines. J Am Geriatr Soc 2003, 51(Suppl 3):S18-S21.
36. Leng S., Chaves P., Koenig K., et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 2002, 50(7):1268-1271.
37. Nikolaisen C., Figenschau Y., Nossent J.C. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol 2008, 35(3):380-386.
38. Ripley B.J., Goncalves B., Isenberg D.A., et al. Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. Ann Rheum Dis 2005, 64(6):849-853.
39. Ferry A.E., Baliga S.B., Monteiro C., et al. Globin gene silencing in primary erythroid cultures. An inhibitory role for interleukin-6. J Biol Chem 1997, 272(32):20030-20037.
40. McDonald T.P., Clift R.E., Cottrell M.B. Large, chronic doses of erythropoietin cause thrombocytopenia in mice. Blood 1992, 80(2):352-358.
41. Beguin Y. Erythropoietin and platelet production. Haematologica 1999, 84(6):541-547.
42. Lu J., Guo S., Ebert B.L., et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008, 14(6):843-853.
43. Hill R.J., Warren M.K., Levin J. Stimulation of thrombopoiesis in mice by human recombinant interleukin 6. J Clin Invest 1990, 85(4):1242-1247.
44. Asano S., Okano A., Ozawa K., et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 1990, 75(8):1602-1605.
45. Sun W.H., Binkley N., Bidwell D.W., et al. The influence of recombinant human interleukin-6 on blood and immune parameters in middle-aged and old rhesus monkeys. Lymphokine Cytokine Res 1993, 12(6):449-455.
46. An E., Ogata K., Kuriya S., et al. Interleukin-6 and erythropoietin act as direct potentiators and inducers of in vitro cytoplasmic process formation on purified mouse megakaryocytes. Exp Hematol 1994, 22(2):149-156.
47. Ramadori G., Van Damme J., Rieder H., et al. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol 1988, 18(8):1259-1264.
48. Nemeth E., Valore E.V., Territo M., et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003, 101(7):2461-2463.
49. Leng S.X., Xue Q.L., Tian J., et al. Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women's Health and Aging Studies I. Exp Gerontol 2009, 44(8):511-516.
50. Friedman J.S., Lopez M.F., Fleming M.D., et al. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood 2004, 104(8):2565-2573.
51. Lyons B.L., Lynes M.A., Burzenski L., et al. Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient "viable motheaten" mice. Exp Hematol 2003, 31(3):234-243.
52. Marinkovic D., Zhang X., Yalcin S., et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest 2007, 117(8):2133-2144.
53. Rocha-Pereira P., Santos-Silva A., Rebelo I., et al. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 2004, 150(2):232-244.
54. Semba R.D., Ferrucci L., Cappola A.R., et al. Low serum selenium is associated with anemia among older women living in the community: the Women's Health and Aging Studies I and II. Biol Trace Elem Res 2006, 112(2):97-107.
55. Semba R.D., Ricks M.O., Ferrucci L., et al. Low serum selenium is associated with anemia among older adults in the United States. Eur J Clin Nutr 2009, 63(1):93-99.
56. Lu J., Holmgren A. Selenoproteins. J Biol Chem 2009, 284(2):723-727.
57. Ania B.J., Suman V.J., Fairbanks V.F., et al. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc 1997, 45(7):825-831.
58. Ble A., Fink J.C., Woodman R.C., et al. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med 2005, 165(19):2222-2227.
59. Makipour S., Kanapuru B., Ershler W.B. Unexplained anemia in the elderly. Semin Hematol 2008, 45(4):250-254.
60. Price E.A. Aging and erythropoiesis: current state of knowledge. Blood Cells Mol Dis 2008, 41(2):158-165.
61. Agnihotri P., Telfer M., Butt Z., et al. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc 2007, 55(10):1557-1565.
62. Gazit R., Weissman I.L., Rossi D.J. Hematopoietic stem cells and the aging hematopoietic system. Semin Hematol 2008, 45(4):218-224.
63. Chambers S.M., Goodell M.A. Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 2007, 3(3):201-211.
64. Conboy I.M., Conboy M.J., Wagers A.J., et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433(7027):760-764.
65. Rivard A., Berthou-Soulie L., Principe N., et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 2000, 275(38):29643-29647.
66. Frenkel-Denkberg G., Gershon D., Levy A.P. The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice. FEBS Lett 1999, 462(3):341-344.
67. Steensma D.P., Tefferi A. Anemia in the elderly: how should we define it, when does it matter, and what can be done?. Mayo Clin Proc 2007, 82(8):958-966.
68. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352(10):1011-1023.
69. Greenberg P.L., Young N.S., Gattermann N. Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program 2002, 136-161.
70. Ferrucci L., Guralnik J.M., Woodman R.C., et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 2005, 118(11):1288.
71. Ershler W.B., Sheng S., McKelvey J., et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc 2005, 53(8):1360-1365.
72. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006, 355(20):2085-2098.
73. Katodritou E., Verrou E., Hadjiaggelidou C., et al. Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma. Am J Hematol 2008, 83(9):697-701.
74. Wright J.R., Ung Y.C., Julian J.A., et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 2007, 25(9):1027-1032.
75. Mima T., Nishimoto N. Clinical value of blocking IL-6 receptor. Curr Opin Rheumatol 2009, 21(3):224-230.
76. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998, 396(6706):77-80.
77. Lanas A., Garcia-Rodriguez L.A., Arroyo M.T., et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006, 55(12):1731-1738.
78. Fleischman A., Shoelson S.E., Bernier R., et al. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 2008, 31(2):289-294.
79. Mielants H., Veys E.M., Verbruggen G., et al. Comparison of serum salicylate levels and gastro-intestinal blood loss between salsalate (Disalcid) and other forms of salicylates. Scand J Rheumatol 1981, 10(3):169-173.
80. Cesari M., Penninx B.W., Pahor M., et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004, 59(3):242-248.
81. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003, 49(10):1573-1578.
82. Knovich M.A., Storey J.A., Coffman L.G., et al. Ferritin for the clinician. Blood Rev 2009, 23(3):95-104.
83. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130(6):461-470.